About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,767 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,767 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3961-3980 of 4,767 trials

CompletedA Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid TumorsThe purpose of this study is to confirm the safety and tolerability of TAK-931 in a cohort of Western participants with metastatic solid tumors and to evaluate the anti-tumor…NCT03261947·Denver, Colorado and 9 others CompletedRole of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic CancerThe investigators hypothesize that the CXCR2 ligands/CXCR2 biological axis plays an important role in promoting angiogenesis in PC; and that the genetic changes and the…NCT00851955·Jacksonville, Florida WithdrawnGI-4000 With Adoptive Transfer in Pancreatic CancerThe purpose of this study is to determine if it is safe to add multiple immunotherapies to standard chemotherapy and radiation for treating pancreatic cancer tumors that cannot be…NCT00837135

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

TerminatedIn Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic CancerThe investigators plan to enroll 30 evaluable patients with (1) a histological diagnosis of advanced pancreatic ductal adenocarcinoma who have demonstrated at least stable disease…NCT03492164·Philadelphia, Pennsylvania

CompletedA Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002The purpose of this study is to continue the safety and immunogenicity of AGS-1C4D4 administered in combination with gemcitabine in subjects previously treated in protocol 2008002.NCT01608711·Madison, Wisconsin and 1 other

CompletedLenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)The goal of this clinical research study is to find the highest tolerable doses of the combinations of lenalidomide and other drugs that can be given to patients with advanced…NCT01183663·Houston, Texas

Unknown68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine TumorsNeuroendocrine cancer is an unusual disease and often goes undetected by routine imaging.NCT02038738·Kenner, Louisiana

TerminatedStudy of NMS-03305293 in Pts with Selected Advanced/Metastatic Solid TumorsPhase I, first-in-human, open-label, multicenter, dose-escalation and dose expansion study with the aim of exploring safety, tolerability and preliminary antitumor activity of…NCT04182516·Houston, Texas and 9 others

RecruitingPrehab for Pancreatic Cancer SurgeryThe goal of this clinical study is to test whether a structured prehabilitation program can be successfully used by adults with pancreatic cancer who are receiving chemotherapy…NCT07478185·Worester, Massachusetts

UnknownMacrophages Effect on ChemoresistanceMacrophages are derived from monocytes recruited to the tumor site and stimulated by specific chemokines secreted by tumor cells.NCT01921699

CompletedA Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic CancerThis is a clinical study to observe the tolerance and primary efficacy of AL2846 capsules combined with Gemzar injection in patients with pancreatic cancer, and to determine the…NCT06278493·Tianjin, Tianjin Municipality

CompletedA Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic CancerThe objective of study IOA-289-102 is to evaluate the safety and tolerability of escalating doses of IOA-289 in patients with metastatic pancreatic cancer in combination with…NCT05586516·Verona, Verona and 2 others

CompletedBlood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsThe primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay…NCT03662204·Phoenix, Arizona and 118 others

UnknownTreatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-mesoRATIONALE: Placing a tumor antigen chimeric receptor that has been created in the laboratory into patient autologous or donor-derived T cells may make the body build immune…NCT02580747·Beijing, Beijing Municipality

CompletedDifferentiation Benign and Malignant Pancreatic LesionsThe MVIT-MLKA model, with its complex architecture combining CNNs and Transformers, excels in image feature extraction and capturing long-range dependencies.NCT06641947·Chongqing, Chongqing Municipality

UnknownPredictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant TherapyRadical surgical resection is the only curative treatment option for pancreatic cancer, but borderline resectable tumors have a high probability of incomplete exeresis.NCT05489458

UnknownCirculating Tumor DNA Exposure in Peripheral BloodThis is a prospective, multi-center, blinded feasibility study.NCT03517332·Tucson, Arizona and 5 others

CompletedSafety Study of Whole Body Hyperthermia for Advanced CancerMillions of patients die of cancer every year. There are several methods to treat cancer, including surgery, chemotherapy, radiotherapy and immunotherapy.NCT04467593·Edegem, Antwerpen

CompletedStudy of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in CancerThe purpose of this study is to determine the safety of glufosfamide when administered in combination with gemcitabine.NCT00102752·Tucson, Arizona and 8 others

CompletedAMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsRATIONALE: AMG 706 and octreotide may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT00427349·Berwyn, Illinois and 111 others

PreviousPage 199 of 239Next